|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sA4960040-3BBC-11EF-ABE7-751685CE164B&I=39IZM&T=&OP=Display&O=html&O1=12911091&O2=3710000000479512&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DNext%2520batter%2520up%2521%2520Targeting%2520cancers%2520with%2520KRAS-G12D%2520mutations%26rft.au%3DAshwood%252C%2520Lauren%2520M.%26rft.au%3DKondrashova%252C%2520Olga%26rft.au%3DSutherland%252C%2520Kate%2520D.%26rft.au%3DZeissig%252C%2520Mara%2520N.%26rft.date%3D2023-11-01%26rft.epage%3D967%26rft.externalDocID%3DS2405803323001371%26rft.genre%3Darticle%26rft.issn%3D2405-8033%26rft.issue%3D11%26rft.jtitle%3DTrends%2520in%2520Cancer%26rft.pub%3DElsevier%2520Inc%26rft.spage%3D955%26rft.volume%3D9%26rft_id%3Dinfo%253Adoi%252F10.1016%252Fj.trecan.2023.07.010%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS-getFullTxt-object,2-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_20221021_LCL-getFullTxt-object,3-UNPAYWALL-getFullTxt-object,4-COBIB_SI_LCL-getHolding-object,5-DOI-getDOI-object,6-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,7-REFWORKS_EXPORT_TOOL-getReference-object,8-GOOGLE_SCHOLAR_FREE-getWebSearch-object,9-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.418865&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12911091-sA4960040-3BBC-11EF-ABE7-751685CE164B" timestamp="2024-07-06T19:24:48Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:3710000000479512</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Next batter up! Targeting cancers with KRAS-G12D mutations</jnl:atitle>
<jnl:jtitle>Trends in Cancer</jnl:jtitle>
<jnl:date>2023-11-00</jnl:date>
<jnl:spage>955</jnl:spage>
<jnl:epage>967</jnl:epage>
<jnl:issn>2405-8033</jnl:issn>
<jnl:volume>9</jnl:volume>
<jnl:issue>11</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2405-8025</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:d02ba63a47017eb32ac6c9abd18e70341f7f16f8</ctx:identifier>
<ctx:identifier>urn:UUID:sA4960040-3BBC-11EF-ABE7-751685CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)